Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLLY: Alternating Estradiol/Anti-estrogen Therapies in ER+/HER2- Metastatic Breast Cancer
NCT02188745Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Mar 2016
- Primary completion
- Jan 2024
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in breast cancer, sponsored by Dartmouth Health. Started Mar 2016; status: completed.
02
Drugs
estradiol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02188745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188745.